MedPath

comparative evaluation of the effect of misoprostol vaginal suppository to vaginal misoprostol with nitroglycerine in rippening of cervix in term pregnancy reffered to kowsar hospital

Phase 2
Conditions
Ripening cervix.
Registration Number
IRCT20120428009576N4
Lead Sponsor
Qazvin University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
106
Inclusion Criteria

Primigravida
Gestational age>=37 week
Bishop score<=4
Cephalic presentation
Reactive NST
Viable fetus
Estimated weight before 4 kilogram
Amniotic fluid >5
Singleton

Exclusion Criteria

Surgery on the uteus or previous cesarean section
chronic hypertension and preeclampsia
uterine contractions
The presence of heart, kidney and liver disease
rapture of membrane
IUGR
Suspected embryonic anomalies
chorioamnionitis
Fever above 38 ° C
polyhydramnios
Pre-delivery hemorrhage
fetal distress

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The duration of cervical ripening until delivery. Timepoint: 6 and 12 hours. Method of measurement: Vaginal exam.
Secondary Outcome Measures
NameTimeMethod
Duration of taking the drug until the onset of the active phase of labor. Timepoint: every 2 hours. Method of measurement: Vaginal exam.;Duration of taking drug until delivery. Timepoint: every 2 hours. Method of measurement: Vaginal exam.;Duration of the fist phase of labor. Timepoint: every 2 hours. Method of measurement: Vaginal exam.;Duration of the second phase of labor. Timepoint: every 1 hours. Method of measurement: Vaginal exam.;Reach to vaginal delivery. Timepoint: After delivery. Method of measurement: Date sheet.;Type of delivery. Timepoint: After delivery. Method of measurement: Date sheet.
© Copyright 2025. All Rights Reserved by MedPath